Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Clinical trial NCT01107535 · COMPLETED

Trial details

NCT number: NCT01107535
Sponsor: Abbott
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Virus Infection

Start date: 2007-09-01
Primary completion: 2011-02-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.